אודות פרק זה

אנגלית
ארצות הברית

תעתיק 🔗

חיפוש פרקים ישנים

חפש פרקים קודמים של Oncology Data Advisor.

פרקים אחרים בפודקאסט הזה

Frontline treatment selection for newly diagnosed multiple myeloma (NDMM) is more complex than ever. With quadruplet regimens and anti-CD38 antibodies redefining the landscape, how do you choose the right therapy for each unique patient? In this exclusive preview, Ashley Chen, PharmD, BCOP (Fred ‮…
View the full article at: https://oncdata.com/oncology-unfiltered-tumor-board-vs-tuesday-afternoon Tumor boards play a pivotal role in oncology care. For clinicians, they represent the ideal environment: multiple specialists, shared context, and time to debate the gray areas that guidelines can‮…
Read the full article here: https://oncdata.com/information-overload-and-the-portal-patient The way that patients receive medical information has changed dramatically. Through electronic health record portals, laboratory values, imaging reports, and pathology results often become available the m‮…
What if hitting prostate cancer earlier and harder is the key to delaying disease progression and sparing patients from invasive salvage therapies? In this follow-up to his i3 Health Virtual Tumor Board, Stephen Freedland, MD, Cedars-Sinai Medical Center, unpacks practice-changing data from ASCO ‮…
Read the full article here! https://oncdata.com/personalizing-cancer-prevention-ai-enhanced-imaging As healthcare increasingly shifts from reactive treatment to proactive prevention, artificial intelligence (AI) is emerging as a powerful tool for identifying disease earlier and personalizing pat‮…
הצהרה: הפודקאסט והגרפיקה המוטבעים בדף זה הם מ-i3 Health, שהוא רכושו של בעליו ואינו קשור או מאושר על ידי Listen Notes, Inc.